Why U.S. Medical Device Market Entry Requires an Ecosystem, Not Just Software

Illustration of a MedTech professional presenting a connected U.S. medical device market entry ecosystem on a digital screen. The network highlights regulatory strategy, quality management, clinical evidence, reimbursement, manufacturing, distribution, provider adoption, post-market surveillance, and software, emphasizing the need for an integrated approach to successful U.S. market entry.

Key Takeaways U.S. medical device market entry requires coordinated regulatory, clinical, quality, technical, manufacturing, economic, institutional, and post-market readiness. FDA authorization permits medical device commercialization but does not ensure reimbursement, hospital adoption, technical integration, manufacturing readiness, or scalability. MedTech software should connect fragmented systems and evidence, while expert governance remains responsible for regulatory, quality, and…

Read More

Quality Management Systems in Medical Device Manufacturing: What You Need to Know

What you need to know about the regulatory framework required for medical device manufacturing.

It’s critical for Medical Device Manufacturers to understand the regulatory framework governing their Quality Systems. Quality management systems ensure medical devices are manufactured consistently, safely, and in compliance with FDA regulations. They establish processes, documentation, and controls that translate design specifications into reliable production outcomes while maintaining traceability and accountability. For manufacturers, the QMS serves…

Read More

Celerity MedTech Alliance: Enlil Announces New Partnership

Enlil announces alliance partnership with Celerity MedTech

Enlil and Celerity MedTech are joining forces to help MedTech teams connect expert development strategy with AI-powered traceability, documentation, and regulatory readiness. Bringing a medical device from concept to market takes more than a clever idea. It demands technical planning, regulatory foresight, quality discipline, commercial strategy, and tight teamwork. When those pieces sit across departments,…

Read More

FDA AI Action Plan Explained

Enlil Blog Post, "FDA AI Action Plan Explained."

A Lifecycle Blueprint for Regulating Adaptive Medical AI The FDA Artificial Intelligence Action Plan outlines the agency’s lifecycle-oriented approach to overseeing AI and machine learning–based medical software in the United States. Specifically, it responds to the limitations of traditional regulatory models when applied to adaptive systems and reflects modern software development and real-world clinical deployment.…

Read More

21 CFR Part 820 Explained: A Complete Guide

Enlil-Blog_21-CFR-820-Explained-Image

Understanding FDA Quality System Regulation Requirements for Medical Device Manufacturers 21 CFR Part 820 establishes the Quality System Regulation governing the design, manufacture, and control of medical devices for the US market. It serves as the FDA’s primary framework for evaluating whether manufacturers consistently produce safe, effective, and compliant devices across the entire product lifecycle.…

Read More

MedTech Product Development Trends in 2026

Enlil Blog: MedTech Product Development Trends in 2025_Post Image

From Embedded AI to Regulatory Alignment: Building the Next Generation of Medical Devices Medical technology development is evolving rapidly. Increasing regulatory scrutiny, digital transformation, and growing engineering complexity are fundamentally changing how devices are designed, validated, and scaled. As a result, technical leaders must adopt system-level thinking and coordinate strategies across the entire product lifecycle.  This…

Read More